Drug-eluting stents in the management of peripheral arterial disease

References

• Abou-CheblABashirQYadavJSDrug-eluting stents for the treatment of intracranial atherosclerosis: initial experience and midterm angiographic follow-upStroke2005361658
   PubMed Web of Science ®Google Scholar
• BosiersMDelooseKVerbistJPercutaneous transluminal angioplasty for treatment of “below-the-knee” critical limb ischemia: early outcomes following the use of sirolimus-eluting stentsJ Cardiovasc Surg(Torino)2006471716
   PubMed Web of Science ®Google Scholar
• BosiersMDelooseKVerbistJNitinol stenting for treatment of ‘below-the-knee’ critical limb ischemia: 1 year angiographic outcome of the Xpert stentJ Cardiovasc Surg(Torino)20074845561
   PubMed Web of Science ®Google Scholar
• ChimowitzMILynnMJHowlett-SmithHWarfarin-aspirin symptomatic intracranial disease trial investigators: comparison of warfarin and aspirin for symptomatic intracranial arterial stenosisN Engl J Med200535213051615800226
   PubMed Web of Science ®Google Scholar
• CommeauPBarraganPRoquebertPOSirolimus for below the knee lesions: mid-term results of SiroBTK studyCatheter Cardiovasc Interv200668793817039538
   PubMed Web of Science ®Google Scholar
• DienerHCBogousslavskyJBrassLMMATCH InvestigatorsAspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trialLancet2004364331715276392
   PubMed Web of Science ®Google Scholar
• DudaSHPusichBRichterGSirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: Six-month resultsCirculation20021061505912234956
   PubMed Web of Science ®Google Scholar
• DudaSHBosiersMLammerJSirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: The SIROCCO II trialJ Vasc Interv Radiol16331815758128
   PubMed Web of Science ®Google Scholar
• DudaSHBosiersMLammerJDrug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: Long-term results from the SIROCCO trialJ Endovasc Ther2006137011017154704
   PubMed Web of Science ®Google Scholar
• EisensteinELAnstromKJKongDFClopidogrel use and long-term clinical outcomes after drug-eluting stent implantationJAMA20072971596817148711
   PubMed Web of Science ®Google Scholar
• FeiringAJWesolowskiAALadeSPrimary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication: early and one-year outcomesJ Am Coll Cardiol20044423071415607391
   PubMed Web of Science ®Google Scholar
• FeiringAJWesolowskiAAAntegrade popliteal artery approach for the treatment of critical limb ischemia in patients with occluded superficial femoral arteriesCatheter Cardiovasc Intervi20076966570
   PubMed Web of Science ®Google Scholar
• GranilloGAvan DijkLCMcFaddenEPPercutaneous radial intervention for complex bilateral renal artery stenosis using paclitaxel eluting stentsCatheter Cardiovasc Interv20056423715619320
   PubMed Web of Science ®Google Scholar
• GuptaRAl-AliFThomasAJSafety, feasibility, and short-term follow-up of drug-eluting stent placement in the intracranial and extracranial circulationStroke2006372562616960090
   PubMed Web of Science ®Google Scholar
• HarperRWDrug-eluting stents coronary stents - a note of cautionMed J Aust2007186253517391089
   PubMed Web of Science ®Google Scholar
• HillRBagustABakhaiACoronary artery stents: a rapid systematic review and economic evaluationHealth Technol Assess2004835iiiiv124215361315
   PubMed Web of Science ®Google Scholar
• HolmesDRLeonMBMosesJWAnalysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosisCirculation20041096344014769686
   PubMed Web of Science ®Google Scholar
• KakkarAKFischiMNarinsCRDrug-eluting stent implantation for treatment of recurrent renal artery in-stent restenosisCatheter Cardiovasc Interv20066811822 discussion 123–416763993
   PubMed Web of Science ®Google Scholar
• KasnerSEChimowitzMILynnMJWarfarin Aspirin symptomatic intracranial disease trialCirculation20061135556316432056
   PubMed Web of Science ®Google Scholar
• KoY-GParkSKimJ-YPercutaneous interventional treatment of extracranial vertebral artery stenosis with coronary stentsYonsei Med J2004456293415344203
   PubMed Web of Science ®Google Scholar
• LevyEIHanelRAHowingtonJUSirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel responseJ Neurosurg20041006889415070124
   PubMed Web of Science ®Google Scholar
• MauriLOravEJCandiaSCRobustness of late lumen loss in discriminating drug-eluting stents across variable observational and randomized trialsCirculation20051122833916267256
   PubMed Web of Science ®Google Scholar
• MorenoRFernandezCHernandezRDrug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studiesJ Am Coll Cardiol200545954915766835
   PubMed Web of Science ®Google Scholar
• NorgrenLHiattWRDormandyJATASC II working groupIntersociety consensus for the mangement of peripheral arterial disease (TASC II)Eur J Vasc Endovasc Surg200733Suppl 1S17517140820
   PubMedGoogle Scholar
• Nussbaumer-OchsnerYEberliFRBaumgartnerRWSirolimus-eluting stenting of the external carotid artery for the treatment of ocular ischemiaJ Endovasc Ther200613672517042660
   PubMed Web of Science ®Google Scholar
• QureshiAIKirmaniJFHusseinHMEarly and intermediate-term outcomes with drug-eluting stents in high-risk patients with symptomatic intracranial stenosisNeurosurgery20065910445117143239
   PubMed Web of Science ®Google Scholar
• RoironCSanchezPBouzamondoADrug eluting stents: an updated meta-analysis of randomised controlled trialsHeart200692641916216853
   PubMed Web of Science ®Google Scholar
• SapovalMZahringerMPattynamaPLow-profile stent system for treatment of atherosclerotic renal artery stenosis: The GREAT trialJ Vasc Interv Radiol200516119520216151060
   PubMed Web of Science ®Google Scholar
• ScheinertDUlrichMScheinertSComparison of sirolimus-eluting vs. bare-metal stents for the treatment of infrapopliteal obstructionsEuroInterv2006216974
   PubMedGoogle Scholar
• Schwarzmaier-D’AssieAKarnikRFracture of a drug-eluting stent in the tibioperoneal trunk following bifurcation stentingJ Endovasc Ther200714106917291141
   PubMed Web of Science ®Google Scholar
• SiablisDKraniotisPKarnabatidisDSirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center studyJ Endovasc Ther2005126859516363898
   PubMed Web of Science ®Google Scholar
• SiablisDKarnabatidisDKatsanosKSirolimus-eluting versus bare stents after suboptimal infrapopliteal angioplasty for critical limb ischemia: enduring 1-year angiographic and clinical benefitJ Endovasc Ther2007142415017484536
   PubMed Web of Science ®Google Scholar
• StoneGWEllisSGCoxDAOne-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trialCirculation20041091942715078803
   PubMed Web of Science ®Google Scholar
• SSYLVIA InvestigatorsStenting of symptomatic atherosclerotic lesions in the vertebral or intracranial arteries (SSYLVIA): study resultsStroke20043513889215105508
   PubMed Web of Science ®Google Scholar
• WaksmanRUpdate on bioabsorbable stents: From bench to clinicalJ Interven Cardiol20061941421
   PubMedGoogle Scholar
• ZähringerMSapovalMPattynamaPMTSirolimus-elutinG versus bare-metal low-profile stent for REnal Artery Treatment (GREAT trial): Angiographic follow-up after 6 month and clinical outcome up to 2 yearsJ Endovasc Ther200714460817696619
   PubMed Web of Science ®Google Scholar
• ZellerTRastanARothenpielerURestenosis after stenting of atherosclerotic renal artery stenosis: Is there a rationale for the use of drug-eluting stents?Catheter Cardiovasc Interv2006681253016755597
   PubMed Web of Science ®Google Scholar